AOD 9604 is a fragment of human growth hormone studied for its effect on fat metabolism, with a real but modest evidence base and an important regulatory caveat: it is not an FDA-approved weight loss drug
Among the patients who took lorcaserin and achieved a 5% or more weight loss after 1 year, more patients who continued taking lorcaserin during the second year (67.9%) were able to maintain their weight loss compared to those who received the placebo during the second year (50.3%)
In bad cases, it can cause megaloblastic anemia
Reduces Fine Lines and Wrinkles GHK-Cu helps reduce the depth and visibility of fine lines by increasing glycosaminoglycans (such as hyaluronic acid), which plumps the skin and restores volume
Maybe they're seeking particular aesthetic changes or mood changes, et cetera
The common side effects and safety considerations for Semaglutide are gastrointestinal issues, gallbladder events, pancreatitis, and renal effects